Actuate Therapeutics Inc (ACTU) Total Return Calculator with Dividends Reinvested

Actuate Therapeutics Inc

Popular:

The total return for Actuate Therapeutics Inc (ACTU) stock is -76.54% over the past 12 months. So far it's down 66.50% this year. The 5-year total return is -76.54%, meaning $10,000 invested in ACTU stock 5 years ago would be worth $2,346 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in ACTU 1 year ago, it would be worth $2,335 today — you'd have lost $7,665.

With Dividends Reinvested$2,335-76.65%

Price Only (No DRIP)$2,335-76.65%

Period2025-06-13 → 2026-06-12

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in ACTU

1Y$2,346-$7,654 (-76.5%)-76.5% CAGR

3Y$2,346-$7,654 (-76.5%)-38.3% CAGR

5Y$2,346-$7,654 (-76.5%)-25.2% CAGR

10Y$2,346-$7,654 (-76.5%)-13.5% CAGR

15Y$2,346-$7,654 (-76.5%)-9.2% CAGR

20Y$2,346-$7,654 (-76.5%)-7.0% CAGR

30Y$2,346-$7,654 (-76.5%)-4.7% CAGR

Actuate Therapeutics Inc did not pay dividends during this period. Total return = price return.

Loading ACTU total return...

As of 2026-06-13

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-66.50%	—	-66.50%	—	$3,350
1Y	-76.54%	-76.54%	-76.54%	—	$2,346
3Y	-76.54%	-38.32%	-76.54%	—	$2,346
5Y	-76.54%	-25.17%	-76.54%	—	$2,346
10Y	-76.54%	-13.50%	-76.54%	—	$2,346
15Y	-76.54%	-9.21%	-76.54%	—	$2,346
20Y	-76.54%	-6.99%	-76.54%	—	$2,346
30Y	-76.54%	-4.72%	-76.54%	—	$2,346

Risk & Highlights

Best Year-7.55%2024

Worst Year-23.12%2025

Max Drawdown-80.28%2025-09-04 → 2026-04-10

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-37.98%	-37.98%	—	+0.41%	-38.4pp
2025	-23.12%	-23.12%	—	+16.64%	-39.8pp
2024	-7.55%	-7.55%	—	+24.00%	-31.5pp

ACTU underperformed the S&P 500 by 99.40pp over the past year (-76.54% vs +22.86%).

Loading summary...

ACTU Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
ACTUActuate Therapeutics Inc	$48M	-30.1%	-66.5%	-76.5%	—	-76.5%	-76.5%	-76.5%
IMVTImmunovant, Inc.	$6.9B	+17.3%	+29.8%	+110.9%	—	+55.0%	+213.0%	+237.9%
TPVGTriplePoint Venture Growth BDC Corp.	$226M	-3.1%	-12.7%	-10.7%	+13.7pp	-22.4%	-23.3%	+85.3%
AGIOAgios Pharmaceuticals, Inc.	$1.8B	+3.7%	+8.4%	-14.6%	—	+13.0%	-49.4%	-43.3%
PRAXPraxis Precision Medicines, Inc.	$7.7B	-22.3%	-6.9%	+491.9%	—	+1757.4%	-14.2%	-36.1%
IDYAIDEAYA Biosciences, Inc.	$2.5B	+3.1%	-14.4%	+30.1%	—	+15.0%	+31.8%	+159.0%
MGNXMacroGenics, Inc.	$252M	+12.5%	+146.0%	+155.5%	—	-31.5%	-81.0%	-85.0%
NKTRNektar Therapeutics	$1.2B	-24.3%	+36.8%	+577.9%	—	+594.5%	-77.6%	-73.6%
CRVSCorvus Pharmaceuticals, Inc.	$1.0B	-25.3%	+63.0%	+181.4%	—	+255.1%	+321.6%	-6.1%
ALDXAldeyra Therapeutics, Inc.	$106M	+2.9%	-62.3%	-39.9%	—	-83.4%	-85.7%	-69.4%
CRLCharles River Laboratories International, Inc.	$9.0B	+11.2%	-7.4%	+23.5%	—	-8.7%	-47.2%	+122.4%

Compare:ACTU vs IMVT ACTU vs TPVG ACTU vs AGIO ACTU vs IMVT vs TPVG

About ACTU Dividend Returns

Actuate Therapeutics Inc (ACTU) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of ACTU over the past year?

Actuate Therapeutics Inc (ACTU) delivered a return of -76.54% over the past year. Since ACTU does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in ACTU be worth today?

A $10,000 investment in Actuate Therapeutics Inc one year ago would be worth $2,346 today, representing a loss of $7,654.

Q3Does ACTU pay dividends?

Actuate Therapeutics Inc (ACTU) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For ACTU, the total return equals the price-only return.

Q4Did ACTU beat the S&P 500?

No, Actuate Therapeutics Inc (ACTU) underperformed the S&P 500 by 99.40 percentage points over the past year. ACTU delivered a total return of -76.54%, compared to the S&P 500's 22.86%. This means a passive S&P 500 index fund outperformed ACTU by 99.40pp during this period.

Q5What is ACTU's worst drawdown?

Actuate Therapeutics Inc (ACTU) experienced a maximum drawdown of -80.28% over the past year, declining from its peak on 2025-09-04 to its trough on 2026-04-10. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is ACTU's long-term total return over 10, 20, or 30 years?

Here are Actuate Therapeutics Inc (ACTU)'s long-term returns with dividends reinvested. Over 10 years, the total return is -76.5% (-13.5% CAGR) — $10,000 would have grown to $2,346. Over 20 years: -76.5% total return (-7.0% CAGR) — $10,000 → $2,346. Over 30 years: -76.5% total return (-4.7% CAGR) — $10,000 → $2,346. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was ACTU's best and worst year?

Actuate Therapeutics Inc's best calendar year was 2024 with a total return of -7.5%. Its worst year was 2025 with a total return of -23.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 15.6 percentage points.

How much would $100/month in ACTU be worth today?

Dollar cost averaging calculator · DCA vs lump sum · see how regular investing compounds

Run the Numbers →